secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2025-05-23T23:59:59+00:00
Accession:  0000950170-25-077089
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo Therapeutics effects 1-for-20 reverse stock split effective May 23, 2025
-------------------------------------------------------------------------------

- Stockholders approved reverse split 1:6 to 1:20 at May 14 special meeting; board chose 1:20 on May 21.
- Filed Certificate of Amendment effective 5:01 PM ET May 23; shares trade split-adjusted from May 27.
- No fractional shares issued; cash payment in lieu for stockholders; warrants rounded up to whole share.
- New CUSIP 03835L 504; par value remains $0.001 per share; adjustments to options, RSUs, warrants.
- Reverse split reduces outstanding shares proportionately, no change in percentage ownership for stockholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000095017025077089/0000950170-25-077089-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000095017025077089/apvo-20250523.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-077089

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer